Clinical Trial Update: Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cisplatin plus gemcitabine with or without paclitaxel in stage IV urinary tract cancers has completed. The study included bladder cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis
• Transitional Cell Carcinoma of the Ureter
• Urethral Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 3 | Status: COMPLETED